Recurrence of minimal residual disease in acute myeloid leukemia: a window of opportunity for intervention by Aniket Bankar

Get full text

Myelodysplastic syndrome diagnosed by genetic testing for hereditary cancer: a case report by Sarah Ridd, Larissa Peck, Aniket Bankar, George S. Charames, Jordan Lerner-Ellis, Radhika Mahajan, Peter J. B. Sabatini, Andrew Wong, Janet Malcolmson, Raymond H. Kim

Get full text

Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase by Maria Agustina Perusini, Claire Andrews, Eshetu G. Atenafu, Vikas Gupta, Dawn Maze, Andre C. Schuh, Karen WL. Yee, Aniket Bankar, Marta B. Davidson, Guillaume Richard-Carpentier, Steven M. Chan, Jad Sibai, Aaron D. Schimmer, Mark D. Minden, Hassan Sibai

Get full text

Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial by Hamenth Kumar Palani, Arun Kumar Arunachalam, Uday Kulkarni, Mohammed Yasar, Arvind Venkatraman, Swathy Palanikumar, Reeshma Nair Radhakrishnan, Majeela Solomon, Abirami Rajasekaran, Aniket Bankar, Phaneendra Venkateswara Rao Datari, Sushil Selvarajan, Anu Korula, Pradyot Dash, Dina Schneider, Louisa Wirthlin, Aby Abraham, Biju George, Vikram Mathews

Get full text